Skip to main content

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melek Denizli, Lourdes Elena Salazar Huayna
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2025

Development of a non-invasive ivd for endometrial cancer screening on high-risk populations

IP: Eva Colas Ortega
Collaborators: Antonio Gil Moreno, Irene De la Calle Fuentes
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 201869.5
Reference: CPP2022-009817
Duration: 01/10/2023 - 30/09/2026

Ministerio de Ciencia

Development of a personalised non-invasive diagnosis of endometrial cancer using proteomic markers in cervical fluids and clinical data

IP: Antonio Gil Moreno
Collaborators: Irene De la Calle Fuentes, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 89900
Reference: IFI22/00019
Duration: 01/01/2023 - 31/12/2026

NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO.

IP: Antonio Gil Moreno
Collaborators: Silvia Cabrera Diaz, Marta Rebull Santamaria, Irene De la Calle Fuentes
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 369335
Reference: CPP2021-008440
Duration: 14/02/2022 - 13/02/2025

Ministerio de Ciencia

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Baye Elimane Thiaw

Baye Elimane Thiaw

Maintenance staff and general services
Infectious Diseases
Read more
Paula  Resta

Paula Resta

Predoctoral researcher
Read more
Valeria Rizzuto

Valeria Rizzuto

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Emanuela Greco

Emanuela Greco

Predoctoral researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.